توپيرامات تيڤع ١٠٠ ملغ

Nazione: Israele

Lingua: arabo

Fonte: Ministry of Health

Principio attivo:

TOPIRAMATE 100 MG

Commercializzato da:

TEVA PHARMACEUTICAL INDUST.LTD

Codice ATC:

N03AX11

Forma farmaceutica:

TABLETS

Via di somministrazione:

PER OS

Prodotto da:

TEVA PHARMACEUTICAL INDUSTRIES LTD

Gruppo terapeutico:

TOPIRAMATE

Indicazioni terapeutiche:

Topiramate Teva is indicated as adjunctive therapy for adults and children aged 6 and above with partial onset seizures or generalized tonic-clonic seizures. Topiramate teva is also indicated in adults and children as adjunctive therapy for the treatment of seizures associated with Lennox-Gastaut syndrome . Topiramate Teva is indicated as monotherapy in patients with newly diagnosed epilepsy in adults and children aged 7 years and above or for conversion to monotherapy in patients with epilepsy.Topiramate Teva is indicated in adults for the prevention of migraines. The use of Topiramate Teva in the acute treatment of migraine has not been studied .

Data dell'autorizzazione:

2011-08-01